Is Vikas Lifecare a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vikas Lifecare Ltd is a below average quality company .

Is Vikas Lifecare undervalued or overvalued?

The key valuation ratios of Vikas Lifecare Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone .

What is Vikas Lifecare share price return in the past 10 years?

Data is not available for this company

Is Vikas Lifecare a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vikas Lifecare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Vikas Lifecare Ltd - Stock Valuation and Financial Performance

Name: Vikas Lifecare
Brand: Vikas Lifecare

BSE: 542655 | NSE: VIKASLIFE | Petrochemicals | Small Cap

Place order

Vikas Lifecare Share Price

₹4.15 -0.24 -5.47%
as on 21-Nov'24 16:59

10 Year X-Ray of Vikas Lifecare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	5.7%	4.8%	3.9%	7%	5.9%	6.7%	3.8%	25.4%	-7.1%	6%	-
Value Creation Index ⓘ	-0.6	-0.7	-0.7	-0.5	-0.6	-0.5	-0.7	0.8	-1.5	-0.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	81.1	93.3	101	195	216	156	75	295	463	417	440
Sales YoY Gr.	-	15.1%	7.7%	94.3%	10.5%	-27.7%	-52%	293.4%	56.9%	-9.9%	-
Adj EPS ⓘ	0.8	0	0.1	0	-0	0	0.1	-0	-0.1	0.1	0
YoY Gr.	-	-98.8%	400%	-80%	-200%	NA	200%	-116.7%	NA	NA	-
BVPS (₹) ⓘ	58.4	14.3	14.7	2	1.1	0.7	0.8	1.8	2.3	2.8	3
Adj Net Profit ⓘ	0.3	0	0.2	0.8	-0.6	1.9	4.9	-1.1	-16.4	12.6	2
Cash Flow from Ops. ⓘ	9.1	0.9	0	-23.2	-11.6	3.5	-7.7	-6.8	-110	-51.5	-
Debt/CF from Ops. ⓘ	1.1	10.6	0	-0.9	-3.4	11.5	-5.4	-1	-0.1	-0.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	19.9%	14.1%	77.1%	-9.9%
Adj EPS ⓘ	-22.9%	NA	10.1%	NA
BVPSⓘ	-28.7%	19.8%	49.2%	21.3%
Share Price	-	5.3%	6.2%	-23.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	1.2	0	0.4	0.7	-0.5	2.6	8.2	-0.9	-6.2	3.1	0.4
Op. Profit Mgn % ⓘ	1.9	1.3	0.5	2.1	1.9	6.5	10.4	-0.8	2.4	0.6	-0.4
Net Profit Mgn % ⓘ	0.4	0	0.2	0.4	-0.3	1.2	6.6	-0.4	-3.5	3	0.4
Debt to Equity ⓘ	0.4	0.2	0.3	0.1	0.4	0.8	0.6	0	0.1	0.1	0.1
Working Cap Days ⓘ	82	66	92	153	258	491	896	197	185	251	118
Cash Conv. Cycle ⓘ	41	39	62	75	102	83	19	39	45	108	91

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 0.30%

Sales growth is growing at healthy rate in last 3 years 77.13%

Sales growth is not so good in last 4 quarters at 0.06%

Latest Financials - Vikas Lifecare Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0	-0
TTM Sales (₹ Cr.)	440	458
BVPS (₹.) ⓘ	3	3
Reserves (₹ Cr.) ⓘ	364	357
P/BV ⓘ	1.47	1.49
PE ⓘ	494.59	0.00

From the Market
52 Week Low / High (₹)	4.05 / 7.92
All Time Low / High (₹)	0.76 / 17.89
Market Cap (₹ Cr.)	805
Equity (₹ Cr.)	183.4
Face Value (₹)	1
Industry PE ⓘ	53.8

Management X-Ray of Vikas Lifecare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

12.63

0.00

12.63

12.62

0.07

0.04

0.03

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Vikas Lifecare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Vikas Lifecare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	81	93	101	195	216	156	75	295	463	417
Operating Expenses ⓘ	80	92	100	191	212	146	67	297	452	414
Manufacturing Costs	0	0	0	3	1	1	0	1	0	0
Material Costs	79	91	99	183	202	142	63	286	443	401
Employee Cost	0	0	0	2	1	1	1	1	2	2
Other Costs ⓘ	1	1	1	4	7	2	3	8	6	11
Operating Profit ⓘ	2	1	1	4	4	10	8	-2	11	3
Operating Profit Margin (%)	1.9%	1.3%	0.5%	2.1%	1.9%	6.5%	10.4%	-0.8%	2.4%	0.6%
Other Income ⓘ	1	2	2	6	4	2	1	44	-28	26
Interest ⓘ	2	2	2	7	6	5	5	2	2	2
Depreciation ⓘ	0	0	0	1	1	1	1	1	3	3
Exceptional Items ⓘ	0	0	0	0	1	-4	-4	0	0	0
Profit Before Tax ⓘ	0	1	1	2	3	3	-1	38	-22	23
Tax ⓘ	0	0	0	1	1	1	2	10	-6	4
Profit After Tax	0	1	1	1	2	1	-4	28	-15	19
PAT Margin (%)	0.5%	0.8%	0.7%	0.8%	1.0%	0.9%	-4.7%	9.5%	-3.3%	4.6%
Adjusted EPS (₹)	1.1	0.2	0.2	0.0	0.0	0.0	0.0	0.3	-0.1	0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	22	47	53	162	90	54	67	199	331	461
Share Capital ⓘ	3	28	30	66	66	66	66	110	144	165
Reserves ⓘ	19	20	23	96	24	-13	0	89	187	296
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	10	9	17	20	39	40	41	6	15	21
Long Term Debt	0	0	0	0	8	5	16	2	10	18
Short Term Debt	10	9	17	20	31	35	25	4	5	3
Trade Payables	5	3	8	64	90	151	38	65	57	13
Others Liabilities ⓘ	25	9	0	18	25	10	4	32	26	44
Total Liabilities ⓘ	61	68	79	264	245	255	150	301	428	538
Fixed Assets
Gross Block	1	1	6	5	5	6	7	19	33	45
Accumulated Depreciation	1	1	1	1	2	2	3	4	6	8
Net Fixed Assetsⓘ	0	0	5	3	4	4	4	15	27	37
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	46	45	43	125	52	17	3	86	98	186
Inventories	2	2	3	15	28	30	27	28	11	9
Trade Receivables	9	15	25	113	135	116	71	42	162	139
Cash Equivalents	1	2	1	1	2	0	0	5	9	13
Others Assetsⓘ	1	5	1	7	24	88	43	126	121	154
Total Assets ⓘ	61	68	79	264	245	255	150	301	428	538

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	9	1	-23	-12	4	-8	-7	-110	-51
PBT ⓘ	0	1	2	3	3	-1	38	-22	23
Adjustment ⓘ	2	2	7	4	4	9	-38	35	-21
Changes in Working Capital ⓘ	7	-2	-32	-17	-2	-15	-6	-122	-52
Tax Paid ⓘ	0	0	0	-1	-1	-1	0	-1	-2
Cash Flow From Investing Activity ⓘ	-46	2	-2	0	-1	12	-47	-43	-82
Capex	0	0	-3	-1	-1	-1	-12	-14	-14
Net Investments	-46	1	0	0	-2	12	-37	-48	-65
Others ⓘ	0	0	1	1	1	2	1	19	-3
Cash Flow From Financing Activityⓘ	38	-2	25	13	-4	-4	59	157	138
Net Proceeds from Shares ⓘ	24	0	24	0	0	0	96	150	112
Net Proceeds from Borrowing ⓘ	0	0	0	19	4	11	-14	7	8
Interest Paid ⓘ	-2	-2	-7	-6	-5	-5	-2	-2	-2
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	15	0	8	0	-3	-10	-21	2	20
Net Cash Flow ⓘ	1	0	0	1	-1	0	5	4	4

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	3.15	2.03	1.36	1.37	1.65	1.94	-5.83	21.05	-5.81	4.88
ROCE (%)	5.65	4.83	3.93	7.03	5.88	6.72	3.8	25.39	-7.08	6.02
Asset Turnover Ratio	1.89	1.44	1.36	1.14	0.89	0.63	0.37	1.31	1.27	0.86
PAT to CFO Conversion(x)	N/A	1	0	-23	-6	4	N/A	-0.25	N/A	-2.68
Working Capital Days
Receivable Days	62	48	73	129	199	293	456	70	80	131
Inventory Days	8	7	9	17	35	68	140	34	15	9
Payable Days	29	16	20	72	139	311	542	65	50	32

Vikas Lifecare Ltd Stock News

Vikas Lifecare Ltd FAQs

What is the share price of Vikas Lifecare?

Company share prices are keep on changing according to the market conditions. The closing price of Vikas Lifecare on 21-Nov-2024 16:59 is ₹4.15.

What is the market cap of Vikas Lifecare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Vikas Lifecare stood at ₹805.2.

What is the P/E ratio of Vikas Lifecare?

The latest P/E ratio of Vikas Lifecare as of 21-Nov-2024 16:59 is 494.6.

What is the P/B ratio of Vikas Lifecare?

The latest P/B ratio of Vikas Lifecare as of 21-Nov-2024 16:59 is 1.47.

What is the 52-week high and low of Vikas Lifecare?

The 52-week high of Vikas Lifecare is ₹7.92 and the 52-week low is ₹4.05.

What is the TTM revenue of Vikas Lifecare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vikas Lifecare is ₹440.0 ( Cr.) .

About Vikas Lifecare Ltd

Vikas Lifecare Limited (formerly known as Vikas Multicorp Ltd.) established in the year 1995, is principally engaged in the business of recycling plastic waste and trading of polymer compounds, manufacturing of polymers compounds. The company is polymer additive related Chemicals Trading House, based in the capital city, it has rich domain experience and in-depth knowledge of International and Local Polymers Market.

Having a more than 2-decade strong operating history in the manufacturing of specialty chemicals for plastics industry, arms VLL with in-depth understanding of the product designing and market trends. The Company is having rich domain experience and in-depth knowledge of International and Local Polymer markets.

The company has set an industry benchmark in service quality and value creation for its customers who have patronized it with their trust and loyalty. The company is certified under ISO 9001:2015, for trading and manufacturing of PVC compounds, EVA, PP, PE, BASE polymers, additive and chemicals (meant for plastic processing). Its manufacturing facility is located at Vigyan Nagar, RIICO Industrial area, Shahjahanpur, Rajasthan, Alwar, Rajasthan.

Business area of the company

The company is principally engaged in the business of Recycling Plastic Waste (Recycling Materials) and trading of Polymer Compounds. Until 2019, the company was engaged in the trading of various Polymer Compounds such as Ethylene-vinyl acetate (EVA Compounds), Polyvinyl chloride resins (PVC resins), chlorinated Parrafin, Polyethylene Compound (PE Compounds) and Thermoplastic Rubber Compounds (TPR Compounds). However, subsequent to the acquisition of ‘Recycled and Trading Compounds Division’ of group concern ‘Vikas Ecotech Limited’ under the scheme of arrangement approved by National Company Law Tribunal, Principal Bench, New Delhi, the company also started manufacturing Polymer Compounds such as PE Compound, Polyvinyl Chloride Compound (PVC Compounds), V blend SOE Compound, Polypropylene Compounds (PP granules), TPR Compounds from FY 2019-20 onwards.